Shield Blood Test Cost Without Insurance (2026) and Coverage

If you want regular lab tests you can order yourself, compare sellers on the best blood tests page or see price per measured marker.

What the Shield blood test is

Guardant describes Shield as "a qualitative, in vitro diagnostic test intended to detect colorectal cancer derived alterations in cell-free DNA" (Shield, read 10 Nov 2026). In plain words, it looks in a blood sample for tiny pieces of DNA that tumor cells can shed. It is meant for "individuals at average risk for the disease, age 45 years or older." The same page says "The Shield blood test is FDA approved."

The National Cancer Institute says Shield is approved "for screening adults ages 45 and older who are at average risk for the disease." It also says "Blood-based tests have not yet been incorporated into clinical guidelines for first-line colorectal cancer screening" (NCI, read 10 Nov 2026). So it is one option to talk through with your clinician, next to the stool tests and colonoscopy that guidelines list.

Shield blood test cost without insurance

This is the cash price Guardant lists for people whose insurance does not cover the test in full.

Guardant's page says the cash rate applies if insurance does not fully cover the test. It does not list a separate draw fee on that page. Your clinic may bill a visit or draw fee of its own, so ask the office what else is charged. Prices can change, so confirm the amount with the ordering office before the draw.

Who can order it

Shield is available by prescription only. Guardant says "The Shield blood draw can be easily completed at any healthcare provider visit." That means your doctor or another licensed clinician places the order. It is not sold through the direct-to-consumer lab stores we compare, which is why it has no row in our price tables. For tests you can order yourself, see ordering your own blood test.

Shield and Medicare coverage

Guardant's page says the test is "widely covered, including by VA CCN, Medicare, and UnitedHealthcare" (Shield). Medicare's own rule is the better source for the details. It covers non-invasive biomarker screening tests for ages "45 to 85 years," and says they are "covered once every 3 years." The test "must be Food and Drug Administration (FDA) market authorized and indicated for colorectal cancer screening" (CMS coverage database, read 10 Nov 2026).

The rule also sets performance floors, measured against colonoscopy. A test must have "a sensitivity of greater than or equal to 90% and a specificity greater than or equal to 87%." The other option is "a sensitivity of greater than or equal to 79% and a specificity of greater than or equal to 90%." Sensitivity is how often a test catches cancer that is there. Specificity is how often it correctly clears people who do not have it. Whether your own plan pays is a question for the plan and your clinician.

What a negative or positive result does

Guardant's page says a negative result does not rule out cancer, and asks people to "continue participating in colorectal cancer screening programs at the appropriate guideline-recommended intervals." What a result means for you is for your clinician to explain. This page covers cost and access only.

Other ways to pay

Some people use an HSA or FSA card for a clinician-ordered test. Our HSA and FSA guide shows what the lab stores we track say about those cards. For a multi-cancer blood test, see the Galleri test cost guide. For another single-test price page built the same way, see the PSA test cost guide, and for the full list see the no-insurance price hub.